About NanoString
NanoString is a Healthcare company based in Seattle (United States) founded in 2003 by Dwayne Dunaway, and was acquired by Bruker in April 2024. It operates as a tools for translational research and molecular diagnosis are developed. NanoString has raised $107.93 million across 15 funding rounds from investors including SVB, Morgan Stanley and Blackstone. Its website nanostring.com draws about 95 thousand monthly visits. Its focus areas include Life Sciences, Genomics, Diversified and Life Sciences Platforms and Tools. Its competitors include Horizon Discovery, GSK, Avidity Biosciences, Quanterix and Sutro Biopharma and 5 more; 9 of its 10 listed competitors have raised funding.
Company details
NanoString was founded in 2003 in Seattle, United States, within the life sciences sector. Tools for translational research and molecular diagnosis are offered through technologies that enable protein and RNA expression analysis. Key products include the GeoMx Digital Spatial Profiler for spatial profiling and the nCounter Analysis system, which utilizes patented molecular barcode technology for digital detection. Operations focus on supporting research and diagnostic applications in biotechnology.
Apps and channels of NanoString
its YouTube channel Bruker Spatial Biology has 2.43K subscribers and 30 videos.
Videos from NanoString
The most watched videos on NanoString's YouTube channel, Bruker Spatial Biology (2.43K subscribers). Click a video to play it here.
More on Bruker Spatial Biology.
Funding Insights of NanoString
NanoString has successfully raised a total of $107.93M across 15 strategic funding rounds. The most recent funding activity was a Post-IPO round of $200 million completed in March 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $107.93M
- Total Rounds 15
- Last Round Post-IPO — $200M
- First Round $4.3M
(Aug 2004)
- Investors Count 11
Latest 10 of 15 funding rounds of NanoString with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2020 | $200M | Post-IPO | – | – | – |
| Jan 2020 | – | Grant | – | – | |
| Nov 2018 | $20M | Debt – Venture | – | – | |
| Oct 2018 | $100M | Debt – Conventional | – | – | |
| Dec 2012 | $15.32M | Series E | – | Morgan Stanley, Blackstone | – |
| Apr 2012 | $15M | Debt – Conventional | – | – | |
| Nov 2011 | $20M | Series D | – | General Electric, BioMedPartners | |
| Jun 2011 | $2.5M | Series C | – | – | – |
| Feb 2010 | $15M | Series C | – | – | |
| Jun 2009 | $30M | Series C | – | Blackstone, Global Life Science Ventures |
12 investors in total: 12 institutional.
Investors in NanoString
NanoString has secured backing from 12 investors, including institutional and venture fund investors. Prominent investors backing the company include SVB, Morgan Stanley and Blackstone.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
CRG is recognized as a premier healthcare investment partner. | – | crglp.com | Houston, United States | |
Diversified investment management is provided across multiple asset classes. | 1985 | blackstone.com | New York, United States | |
US focused VC firm | – | dfj.com | Menlo Park, United States | |
Early to mid stage life sciences-focused VC firm investing in geographies such as Europe | – | biomedvc.com | Basel, Switzerland | |
Early-stage VC investments are focused primarily on US companies. | – | ovpevents.com | Seattle, United States | |
Venture debt firm focused on the life sciences sector | 2002 | oxfordfinance.com | Alexandria, United States | |
Early & late stage life sciences focused VC firm funding companies in the US and Europe | – | global-life-science-ventures.com | Munich, Germany | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Banking services are provided to innovative companies, investors, and individuals. | 1983 | svb.com | Santa Clara, United States | |
Wealth management, investment advisory, and financial services are provided. | 1935 | morganstanley.com | New York, United States |
Investor details for NanoString
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of NanoString
69 people are tracked at NanoString (19 in leadership, 5 in board & advisors, 45 in team).
| Name | Role | Group |
|---|---|---|
Dwayne Dunaway | Co-Founder & Director | Leadership |
Joseph M. Beechem | Chief Science Officer & SVP, Research & Development | Leadership |
Gary Riordan | Vice President, Regulatory Affairs And Quality | Leadership |
Mirna Dipano | Vice President Quality Assurance And Regulatory Affairs | Leadership |
Keith Forbes | Director Of Procurement And S&op | Leadership |
James Rhydderch | Director Of Manufacturing | Leadership |
Evans Nguyen | Director Of Development Engineering | Leadership |
Agnese Winfield | Sr Director, APAC EMEA NA Regional Marketing | Leadership |
Manish Bhatt | Director Of Quality | Leadership |
Marie Beverly | Associate Director, Accounting | Leadership |
Kerry Miljour | Sr. Director, Corporate Controller | Leadership |
Dan Stewart | Director, Global Logistics | Leadership |
Gulam Shaikh | VP R&d: Development | Leadership |
Mark Daniel | Vice President Finance | Leadership |
Erin Lafrance | Sr. Director, Corporate Controller | Leadership |
Melanie Young | Vice President/global Head Of Human Resources-chro | Leadership |
Garima Mehta | Head Of Digital Marketing | Leadership |
Christina B. | Director Product Management & Collaborations | Leadership |
Elizabeth Pitts | Associate Director Of Product Management | Leadership |
William D. Young | Chairman | Board & advisors |
49 more people are available in the full profile.
Complete people profiles for NanoString
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of NanoString
5 dated milestones of NanoString across 21 years, from founding to its latest funding, stage changes and deals.
- Founded NanoString is founded.
- Funding First funding round of $4.3M.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $200.0M.
- Exit Acquired by Bruker.
Competitors of NanoString
NanoString has 10 listed competitors in our database, 9 of them funded. They include Horizon Discovery, GSK, Avidity Biosciences, Quanterix and Sutro Biopharma, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| horizondiscovery.com | 2007 | Cambridge, United Kingdom | $46.29M | 432 | Genetically modified cell lines are developed using AAV gene-editing platform. | |
| gsk.com | 1715 | Brentford, United Kingdom | – | 90,913 | Developer of pharmaceuticals and vaccines for various therapeutic areas | |
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| quanterix.com | 2007 | Cambridge, United States | $99.5M | 141 | Assay kits for ultra-sensitive biomarker detection are developed. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| synthego.com | 2012 | Redwood, United States | $459.75M | – | CRISPR-engineered cell and gene therapies are developed for research applications. | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. | |
| univercells.com | 2013 | Charleroi, Belgium | $150.64M | 87 | Biomanufacturing technologies are supplied for biopharma antibody and vaccine production. |
Detailed competitors of NanoString
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of NanoString
The website of NanoString (nanostring.com) receives about 94.7K visits a month.
- Monthly visits94.7K
▲ 107.9% vs previous month
Websites whose visitors overlap most with NanoString. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| illumina.com | 100% | 672.7K | #61,793 | View details | |
| affymetrix.com | 84% | 1.1K | #9,164,392 | View details | |
| genomatix.de | 78% | – | – | View details | |
genetics.pitt.edu | genetics.pitt.edu | 76% | – | – | – |
| nimblegen.com | 76% | – | – | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for NanoString
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
10 companies that operate in the same segment as NanoString (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 562 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Nanostring
Complete news archive for NanoString
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NanoString
NanoString was founded in 2003 and raised its 1st funding round 1 year after it was founded.
NanoString is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
NanoString is a funded company, having raised a total of $107.93M across 15 funding rounds to date. The company's 1st funding round was a Series C of $30M, raised on Aug 2004.
NanoString was founded in 2003 in Seattle, United States, within the life sciences sector. Tools for translational research and molecular diagnosis are offered through technologies that enable protein and RNA expression analysis. Key products include the GeoMx Digital Spatial Profiler for spatial profiling and the nCounter Analysis system, which utilizes patented molecular barcode technology for digital detection. Operations focus on supporting research and diagnostic applications in biotechnology.
NanoString's top competitors include Horizon Discovery, Sutro Biopharma and Synthego.
NanoString has 12 investors. Key investors include SVB, Morgan Stanley, Blackstone, General Electric, and Bruker.
Yes. NanoString was acquired by Bruker in April 2024.